Infectious Diseases Search
Infectious Diseases Infectious Diseases
rosacea
ROSACEA
Rosacea is a chronic cutaneous disease of the convexities of the central face (cheeks, chin, nose and central forehead) w/ periorbital and perioral skin sparing. This condition is attributed to chronic vasodilation.
Remissions and exacerbations are common.
It typically appears after 30 years of age but may occur at any age.  It commonly affects fair-skinned individuals.
The common presenting symptoms are facial flushing, stinging/burning erythema, telangiectasia, edema, papules, pustules, ocular lesions, and hypertrophy of the sebaceous glands of the nose with fibrosis.
A history of episodic flushing often heralds onset of rosacea.

Definition

  • Chronic inflammatory cutaneous disease of the convexities of the central face (cheeks, chin, nose and central forehead) with periorbital and perioral skin sparing
    • Condition attributed to chronic vasodilation
  • Remissions and exacerbations are common
  • Typically begins after 30 years but may occur at any age, commonly affects fair-skinned individuals

Signs and Symptoms

  • Common presenting symptoms: Facial flushing, stinging/burning sensation, erythema, telangiectasia, edema, papules, pustules, ocular lesions, hypertrophy of the sebaceous glands of the nose with fibrosis (rhinophyma)
    • History of episodic flushing often heralds onset of rosacea
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Girls more likely to show complete response to EoE treatment
5 days ago
Girls with eosinophilic oesophagitis (EoE) who show initial response to directed therapy will tend to continue to respond well to treatment, a recent study has shown.
Single-inhaler triple therapy effective for uncontrolled asthma
Pearl Toh, 3 days ago
Adding a LAMA* to the double combination therapy of ICS** plus LABA*** in a single inhaler improves lung function and reduces exacerbations in patients whose asthma is inadequately controlled with the combination treatment, according to the TRIMARAN and TRIGGER# studies presented at ERS 2019.
FLAURA reinforces osimertinib as new frontline standard for EGFRm advanced NSCLC
Elvira Manzano, 4 days ago
Final overall survival (OS) results from the double-blind phase III FLAURA study reinforce osimertinib as the standard frontline treatment for epidermal growth factor receptor-mutated (EGFRm) non–small cell lung cancer (NSCLC), say leading oncologists at ESMO 2019.
Bisphenol A exposure during pregnancy tied to respiratory problems in offspring
Tristan Manalac, 3 days ago
Babies born to mothers exposed to high levels of bisphenol A during pregnancy are at a greater risk of wheezing and poor lung function, according to a new study presented at the recently concluded International Congress of the European Respiratory Society (ERS 2019).